Assessment of Dietary Biomarkers and Metabolic Effects After the Intake of Milk and Cheese

NCT02705560 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-03-10

No results posted yet for this study

Summary

Dietary biomarkers are compounds in biofluids that directly reflect the intake of specific foods or food groups. Their exploration and use in the field of dietary assessments could provide an objective measure of actual intake complementing classical assessment methods (e.g. food frequency questionnaire, 24h recalls). To date, only a limited number of foods have been covered by validated biomarkers.

The study is part of the international project "The Food Biomarker Alliance (FOODBALL)". The study described here has been assigned to assess biomarkers of the intake of milk and cheese. Up to now, there is an evident lack of data on specific and validated biomarkers of milk and cheese (dairy products), which belong to the most relevant public health related foods in Europe. This study will further provide novel insights into the influence of fermentation of milk-based foods on metabolic effects and postprandial adaptations, which has not yet been studied in depth before using cheese as fermented product. Outcomes will support and expand earlier findings on correlation between the intake of fermented dairy products intake and human health.

Conditions

  • Healthy

Interventions

OTHER

Cow´s milk (3.9% fat, pasteurized)

600 ml full fat milk (organic, pasteurized, 400 kcal)

OTHER

hard, yellow cheese

100 g Swiss cheese (Le Gruyère medium ripe, 400 kcal)

OTHER

Soy based drink

600 ml Soy drink (540 ml soy milk (232 kcal) supplemented with 60 ml soy and plant based cream (167 kcal)

Sponsors & Collaborators

  • Agroscope Liebefeld-Posieux Research Station ALP

    collaborator OTHER
  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • François Pralong, MD · CHUV

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-06-30
Completion
2018-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705560 on ClinicalTrials.gov